Velocity Fund Partners

Velocity Fund Partners is a private equity firm established in 2016 and based in Pittsburgh, Pennsylvania. The firm specializes in investing in the life sciences sector, focusing on product development and healthcare services. Founded by two CEOs with complementary backgrounds in healthcare management and life sciences, Velocity Fund Partners has built a team of experienced professionals in operations and finance. The firm seeks to identify research programs or startup companies that possess a unique scientific advantage, with the potential to significantly enhance the development of medical devices, drugs, diagnostics, and treatment methodologies.

Kenneth Melani MD

Managing Partner

3 past transactions

Scribenote

Seed Round in 2024
Scribenote is a technology company specializing in AI-driven medical scribe solutions for veterinarians. Its platform automates and simplifies the documentation process, reducing administrative tasks and allowing veterinarians to focus more on patient care. The system captures audio, generates transcripts, and creates SOAP notes during appointments, integrating seamlessly with practice management software. This streamlines workflows, enhances client experience, and improves overall efficiency in veterinary clinics.

MedMe

Seed Round in 2021
MedMe Health is a patient care platform that assists pharmacists in scheduling, conducting, and tracking clinical services both virtually and on-site. The platform employs proprietary algorithms to streamline various medical services, including online scheduling, digital diagnosis, documentation filing, and automated follow-up appointments. By facilitating these processes, MedMe Health enables pharmacies to enhance their workflows, strengthen patient relationships, and diversify revenue opportunities within clinical services.

InClinica

Acquisition in 2016
InClinica, Inc. is a global clinical contract research organization (CRO) that offers comprehensive clinical development and pharmaceutical research services to biotechnology and pharmaceutical companies. Founded in 2007 and based in Wayne, Pennsylvania, InClinica specializes in various therapeutic areas, including oncology, metabolic disease, cardiovascular, infectious disease, and women's health, among others. The company assists clients through all phases of clinical trials, with a particular focus on early-phase studies such as first-in-man and Phase 2 trials. InClinica serves a diverse clientele across North America, Europe, Asia, and Latin America, leveraging a senior management team with extensive experience in drug development. The company also operates regional offices in Kuala Lumpur, Malaysia, and has expanded its presence internationally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.